Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

MQR.WA

Strong SellSinker

MultiQure S.A. · Healthcare · Poland · $10M · Avg Vol: $226K/d

3
StockRank
Get insider-trade alerts
Q
15
V
25
M
29
P/E (TTM)
—
ROE
—
D/E
—
Dividend %
—
Dir. Trades · 180d
None →
Buybacks · 180d
None →

COMPANY DESCRIPTION

MultiQure S.A., a biopharmaceutical company, engages in the research and development of biological drugs and medical devices for therapeutic use.

FINANCIAL SUMMARY (PLN)

Year2022202320242025CAGRTTM
Revenue0.7M000——
EPS (PLN)-2.09-4.76-2.38-1.99—-1.68
Shares12.2M7.8M8.8M11.3M-7.5%—
Debt2.9M12.9M14.1M16.0M77.5%16.4M
Equity18.3M1.9M-13.1M-14.1M-89.7%—
Op CF-17.4M-23.3M-10.8M-6.2M—-8.6M
Inv CF15.3M0.4M3.6M0.9M——
Fin CF-1.9M24.2M4.0M5.0M——
Loading 1Y...
PRICE (1Y)+27.0%
0.580.650.730.810.88Jul 28Aug 18Sep 9
SMA 50SMA 200

Close
$0.7351
RSI (14)
33.2
52W High
$2.09
From 52W High
0.4%

SCORE BREAKDOWN

Quality
15
ROIC (ROA)
-211.7%*2.5
ROE
—N/A
GP/Assets
-0.5%8.4
Op. Margin
0.0%38.1
FCF/Assets
-84.2%3.0
Piotroski
321.9
Int. Cover
-2.6x30.7
D/E Ratio
—N/A
Current Ratio
0.09x0.4
Value
25
P/E (TTM)
—N/A
EV/EBITDA
-7.4x25.0
P/FCF
—N/A
P/B
—N/A
P/S
—N/A
Div Yield
—N/A
Momentum
29
52W High %
35%9.9
RS 6M
-13%49.4
SMA 50/200
0.88x27.4
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A

FUNDAMENTALS

Market Cap
$10M
P/E (Forward)
—
Gross Margin
—

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MQR.WA are excluded.

TickerCompanyMkt CapStockRankSignal
MQR.WAMultiQure S.A.(you)$10M3Strong Sell
PUR.WAPure Biologics S.A.$8M3Strong Sell
URT.WAUrteste S.A.$18M12Strong Sell
MAB.WAMabion S.A.$34M10Strong Sell
NNG.WANanoGroup S.A.$28M14Strong Sell
PTG.WAPoltreg S.A.$34M13Strong Sell
MOC.WAMolecure S.A.$40M14Strong Sell
SVE.WASynthaverse S.A.$46M11Strong Sell
RVU.WARyvu Therapeutics S.A.$113M4Strong Sell
CTX.WACaptor Therapeutics Spolka Akcyjna$120M6Strong Sell

Peer medians: ROE -17.6% · P/E 17.0x · Gross margin 30.3%

MultiQure S.A. (MQR.WA): Stock Score Summary

MultiQure S.A. (MQR.WA) has a MoatMap StockRank of 3/100 based on Quality (15/100), Value (25/100), and Momentum (29/100) factor scores. The current signal is STRONG SELL.

MultiQure S.A., a biopharmaceutical company, engages in the research and development of biological drugs and medical devices for therapeutic use.

Key Financial Metrics

Price$0.74
Market Cap$10M
Operating Margin0.0%
Free Cash Flow$-1M

MultiQure S.A. operates in the Biotechnology industry, part of the Healthcare sector (Poland).

Frequently Asked Questions

What is MultiQure S.A.’s (MQR.WA) StockRank?
MoatMap’s StockRank for MultiQure S.A. (MQR.WA) is 3/100, with a Strong Sell signal. It is a composite of Quality (15), Value (25), and Momentum (29) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does MultiQure S.A. have an economic moat?
MultiQure S.A. (MQR.WA) has a Quality factor score of 15/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is MultiQure S.A. a buy, hold, or sell?
MoatMap’s current signal for MultiQure S.A. (MQR.WA) is Strong Sell, based on a StockRank of 3/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is MultiQure S.A. in?
MultiQure S.A. (MQR.WA) operates in the Healthcare sector, specifically the Biotechnology industry (Poland).
Browse all ranked stocksMQR.WA deep dive reportAI ChampionsHow we score stocksSense-check another stock